Santhera Pharmaceuticals Holding AG
SANN
Kedudukan dalam Saham
#16116
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company,... Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company’s lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy. Its clinical stage pipeline also comprises Lonodelestat for the treatment of cystic fibrosis and other neutrophilic pulmonary diseases. Santhera Pharmaceuticals Holding AG was founded in 2004 and is based in Pratteln, Switzerland.
Harga Saham
$19.07
Modal Pasaran
$291.75M
Perubahan (1 hari)
-0.27%
Perubahan (1 tahun)
48.61%
Negara
CH
Perdagangan Santhera Pharmaceuticals Holding AG (SANN)
Kategori
Healthcare
Sejarah pecahan saham untuk Santhera Pharmaceuticals Holding AG (SANN)
Saham Santhera Pharmaceuticals Holding AG (simbol: SANN) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Oct 21, 2026.
Satu saham SANN yang dibeli sebelum Oct 21, 2026 kini bersamaan dengan 0 saham SANN.
Pecahan saham terkini berlaku pada Oct 21, 2026.
Satu saham SANN yang dibeli sebelum Oct 21, 2026 kini bersamaan dengan 0 saham SANN.
Senarai pecahan saham
| Tahun | Pecahan | Gandaan | Gandaan Kumulatif |
|---|---|---|---|
| Tidak cukup data untuk tarikh yang disediakan. | |||
Pecahan saham untuk syarikat pesaing atau serupa
| Syarikat | Bilangan pecahan saham | Gandaan Kumulatif | Negara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
